Though things are looking up for Akero, the stock still looks risky. Akero Therapeutics is developing efruxifermin as a ...

Netflix ( NFLX 0.36%) has shown investors once again who's on top of the streaming industry. On Jan. 21, the company reported ...

On Jan. 27, Nvidia ( NVDA -3.67%) fell 17%, erasing over $590 billion from its market cap. It marked the greatest single-day ...

The stock market's climb over the last few years has driven dividend yields to multiyear lows. The S&P 500 average yield is ...

Although DeepSeek gave investors a scare when its R1 model impressed everyone with its performance at its price point, it's becoming clearer that this breakthrough wasn't a death blow to the domestic ...

Spending on artificial intelligence (AI) has been heating up recently, and it may not necessarily be slowing down. The ...